Prophylactic osteosynthesis of long bones in patients with multiple myeloma.

Q4 Medicine
V Nekuda, D Ira, M Štork, V Válek, Z Knechtová, M Cvanová, L Pour, M Krtička
{"title":"Prophylactic osteosynthesis of long bones in patients with multiple myeloma.","authors":"V Nekuda, D Ira, M Štork, V Válek, Z Knechtová, M Cvanová, L Pour, M Krtička","doi":"10.33699/PIS.2024.103.5.187-192","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Multiple myeloma (MM) is a neoplastic disease caused by clonal proliferation of plasma cells in the bone marrow. The median age of newly diagnosed patients is 69 years. Bone involvement occurs in most patients during the course of the disease. The management of bone involvement in MM includes surgical intervention. Bones affected by osteolytic lesions are weakened and require stabilization through implants or endoprostheses. The intramedullary osteosynthesis method appears to be an ideal choice for stabilizing osteolytic lesions in long bones. The aim of our study was to analyze whether prophylactic fixation of these lesions improves the quality of life of the patients and has any impact on bone changes.</p><p><strong>Methods: </strong>Patients undergoing prophylactic intramedullary osteosynthesis were operated on at the University Hospital Brno between 2013 and 2023. Patients included in this study had osteolytic lesions in long bones, Mirels' score equal to or greater than 8, and a minimum follow-up of 12 months. We evaluated the intensity of pain using a visual analog scale (VAS) assessed before the operation, after the operation, and one-year post-operation. The Musculoskeletal Tumour Society score (MSTS) score was assessed just before the planned stabilization procedure and one year later.</p><p><strong>Results: </strong>At the time of the assessment, a statistically significant difference was found between the VAS score before the operation and 14 days post-operation (p.</p>","PeriodicalId":52413,"journal":{"name":"Rozhledy v Chirurgii","volume":"103 5","pages":"187-192"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rozhledy v Chirurgii","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33699/PIS.2024.103.5.187-192","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Multiple myeloma (MM) is a neoplastic disease caused by clonal proliferation of plasma cells in the bone marrow. The median age of newly diagnosed patients is 69 years. Bone involvement occurs in most patients during the course of the disease. The management of bone involvement in MM includes surgical intervention. Bones affected by osteolytic lesions are weakened and require stabilization through implants or endoprostheses. The intramedullary osteosynthesis method appears to be an ideal choice for stabilizing osteolytic lesions in long bones. The aim of our study was to analyze whether prophylactic fixation of these lesions improves the quality of life of the patients and has any impact on bone changes.

Methods: Patients undergoing prophylactic intramedullary osteosynthesis were operated on at the University Hospital Brno between 2013 and 2023. Patients included in this study had osteolytic lesions in long bones, Mirels' score equal to or greater than 8, and a minimum follow-up of 12 months. We evaluated the intensity of pain using a visual analog scale (VAS) assessed before the operation, after the operation, and one-year post-operation. The Musculoskeletal Tumour Society score (MSTS) score was assessed just before the planned stabilization procedure and one year later.

Results: At the time of the assessment, a statistically significant difference was found between the VAS score before the operation and 14 days post-operation (p.

多发性骨髓瘤患者长骨预防性植骨。
简介:多发性骨髓瘤(Multiple myeloma, MM)是一种由骨髓浆细胞克隆性增生引起的肿瘤疾病。新诊断患者的中位年龄为69岁。大多数患者在病程中发生骨受累。MM骨受累的处理包括手术干预。受溶骨损伤影响的骨骼变弱,需要通过植入物或内假体来稳定。髓内植骨术似乎是稳定长骨溶骨性病变的理想选择。我们研究的目的是分析预防性固定这些病变是否能改善患者的生活质量,并对骨骼变化有任何影响。方法:选取2013 ~ 2023年在布尔诺大学医院行预防性髓内植骨术的患者。本研究纳入的患者有长骨溶骨性病变,Mirels评分等于或大于8分,至少随访12个月。我们采用视觉模拟评分法(VAS)评估术前、术后和术后1年的疼痛程度。肌肉骨骼肿瘤协会评分(MSTS)评分在计划的稳定手术前和一年后进行评估。结果:评估时,术前VAS评分与术后14 d比较,差异有统计学意义(p。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Rozhledy v Chirurgii
Rozhledy v Chirurgii Medicine-Medicine (all)
CiteScore
0.50
自引率
0.00%
发文量
67
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信